User menu

Excess mortality after treatment with fludarabine and cyclophosphamide in combination with alemtuzumab in previously untreated patients with chronic lymphocytic leukemia in a randomized phase 3 trial.

Bibliographic reference Lepretre, Stephane ; Aurran, Therese ; Mahé, Beatrice ; Cazin, Bruno ; Tournilhac, Olivier ; et. al. Excess mortality after treatment with fludarabine and cyclophosphamide in combination with alemtuzumab in previously untreated patients with chronic lymphocytic leukemia in a randomized phase 3 trial.. In: Blood, Vol. 119, no.22, p. 5104-5110 (2012)
Permanent URL http://hdl.handle.net/2078.1/132474